Using MC1R Genotype to Impact Melanoma Risk Behavior

Sponsor
H. Lee Moffitt Cancer Center and Research Institute (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03509467
Collaborator
The Ponce Health Sciences University (Other), University of South Florida (Other), American Cancer Society, Inc. (Other)
2,293
2
4
85.9
1146.5
13.3

Study Details

Study Description

Brief Summary

The purpose of this study is to examine how different messages about risk of melanoma can impact the way people protect themselves against developing these diseases.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Personalized Information
  • Behavioral: Standard Information
  • Other: DNA Extraction Determination of MC1R Genotypes
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
2293 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Using MC1R Genotype to Impact Melanoma Risk Behavior
Actual Study Start Date :
Aug 3, 2015
Actual Primary Completion Date :
Feb 19, 2021
Anticipated Study Completion Date :
Oct 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Group A

Intervention Group A: Non-Hispanic White Population Post determination of MC1R Genotypes, participants randomized to the intervention group, will receive personalized information about ways that they can protect themselves and their child from developing melanoma. By the end of the study, all participants will have had the opportunity to receive information about their inherited risk.

Behavioral: Personalized Information
Personalized information about ways that participants can protect themselves and their child from developing melanoma.
Other Names:
  • educational materials
  • Other: DNA Extraction Determination of MC1R Genotypes
    After signing informed consent, a biologic sample (saliva) will be collected for the purpose of DNA extraction determination of MC1R genotypes. All participants who carry high risk MC1R genotypes and a proportion of those who carry low risk or no MC1R variants will be randomized to the control or intervention arm.
    Other Names:
  • risk factor
  • Experimental: Intervention Group B

    Intervention Group B: Hispanic Population Post determination of MC1R Genotypes, participants randomized to the intervention group, will receive personalized information about ways that they can protect themselves and their child from developing melanoma. By the end of the study, all participants will have had the opportunity to receive information about their inherited risk.

    Behavioral: Personalized Information
    Personalized information about ways that participants can protect themselves and their child from developing melanoma.
    Other Names:
  • educational materials
  • Other: DNA Extraction Determination of MC1R Genotypes
    After signing informed consent, a biologic sample (saliva) will be collected for the purpose of DNA extraction determination of MC1R genotypes. All participants who carry high risk MC1R genotypes and a proportion of those who carry low risk or no MC1R variants will be randomized to the control or intervention arm.
    Other Names:
  • risk factor
  • Placebo Comparator: Control Group A

    Control Group A: Non-Hispanic White Population Post determination of MC1R Genotypes, participants randomized to the control group, you will receive standard information about ways that they can protect themselves and their child from developing melanoma. By the end of the study, all participants will have had the opportunity to receive information about their inherited risk. Participants randomized into the control group, by the end of the study will also have had the opportunity to receive personalized information about ways they can protect themselves and their child from developing melanoma.

    Behavioral: Standard Information
    Standard information about ways that participants can protect themselves and their child from developing melanoma.
    Other Names:
  • educational materials
  • Other: DNA Extraction Determination of MC1R Genotypes
    After signing informed consent, a biologic sample (saliva) will be collected for the purpose of DNA extraction determination of MC1R genotypes. All participants who carry high risk MC1R genotypes and a proportion of those who carry low risk or no MC1R variants will be randomized to the control or intervention arm.
    Other Names:
  • risk factor
  • Placebo Comparator: Control Group B

    Control Group B: Hispanic Population Post determination of MC1R Genotypes, participants randomized to the control group, you will receive standard information about ways that they can protect themselves and their child from developing melanoma. By the end of the study, all participants will have had the opportunity to receive information about their inherited risk. Participants randomized into the control group, by the end of the study will also have had the opportunity to receive personalized information about ways they can protect themselves and their child from developing melanoma.

    Behavioral: Standard Information
    Standard information about ways that participants can protect themselves and their child from developing melanoma.
    Other Names:
  • educational materials
  • Other: DNA Extraction Determination of MC1R Genotypes
    After signing informed consent, a biologic sample (saliva) will be collected for the purpose of DNA extraction determination of MC1R genotypes. All participants who carry high risk MC1R genotypes and a proportion of those who carry low risk or no MC1R variants will be randomized to the control or intervention arm.
    Other Names:
  • risk factor
  • Outcome Measures

    Primary Outcome Measures

    1. Sun and Protection Behaviors - Impact of Risk and Prevention Education - Non-Hispanic White Population [Up to 12 months]

      Rate of self-reported, post education changes per study arm: 1.) decrease in sun exposure, 2.) increase in sun protection.

    2. Sun and Protection Behaviors - Impact of Risk and Prevention Education - Hispanic Population [Up to 9 months]

      Rate of self-reported, post education changes per study arm: 1.) decrease in sun exposure, 2.) increase in sun protection

    3. Skin Awareness and Examination - Impact of Risk and Prevention Education - Hispanic Population [Up to 9 months]

      Rate of self-reported, post education changes per study arm: Increase in skin examinations.

    4. Skin Awareness and Examination - Impact of Risk and Prevention Education - Non-Hispanic White Population [Up to 12 months]

      Rate of self-reported, post education changes per study arm: Increase in skin examinations.

    Secondary Outcome Measures

    1. Impact of Receipt of MC1R Genotype on Sun Protection Behaviors in Children - Non-Hispanic White Population [Up to 12 months]

      Impact of receipt of MC1R genotype on sun protection behaviors in children of study participants. Self-reported post education decreased number of sunburns.

    2. Impact of Receipt of MC1R Genotype on Sun Protection Behaviors in Children - Hispanic Population [Up to 9 months]

      Impact of receipt of MC1R genotype on sun protection behaviors in children of study participants. Self-reported post education decreased number of sunburns.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    CRITERIA FOR: NON-HISPANIC WHITE POPULATION

    • Investigators will recruit participants from the Family Medicine and General Internal Medicine clinics of the Morsani Center at the University of South Florida.

    • White, non-Hispanic patients who self-report a low phenotypic risk profile for development of melanoma and are able to read and speak English fluently.

    • 18 years of age or older

    • Capable of giving informed consent

    • Potential participants will be screened for eligibility based on responses to questions about skin phenotypes, early detection behaviors and past history of melanoma.

    • After signing informed consent, a biologic sample (saliva) will be collected for the purpose of DNA extraction determination of MC1R genotypes. All participants who carry high risk MC1R genotypes and a proportion of those who carry low risk or no MC1R variants will be randomized to the control or intervention arm.

    CRITERIA FOR: HISPANIC POPULATION

    • Investigators will recruit participants living in Tampa Bay and Puerto Rico as part of the U54 Ponce Health Sciences University-Moffitt Cancer Center (PHSU-MCC) Partnership. In Tampa Bay, participants will be recruited from the Family Medicine and General Internal Medicine clinics of the Morsani Center at the University of South Florida, and from the Suncoast Community Health Centers.

    • Patients who self-report as Hispanics and are able to read and speak either Spanish or English fluently.

    • 18 years of age or older

    • Capable of giving informed consent

    • Potential participants will be screened for eligibility based on responses to early detection behaviors and past history of melanoma.

    • After signing informed consent, a biologic sample (saliva) will be collected for the purpose of DNA extraction determination of MC1R genotypes. All participants who carry high risk MC1R genotypes and a proportion of those who carry low risk or no MC1R variants will be randomized to the control or intervention arm.

    Exclusion Criteria:

    CRITERIA FOR: NON-HISPANIC WHITE POPULATION

    • Have had a skin examination within the past year.

    • Do not meet race/ethnicity criteria for their group

    • White, non-Hispanic group - participants reporting sun-sensitive phenotypes

    • A personal history of melanoma

    CRITERIA FOR: HISPANIC POPULATION

    • Have had a skin examination within the past year.

    • Do not meet ethnicity criteria for their group

    • White, non-Hispanic group - participants reporting sun-sensitive phenotypes

    • Participants with a personal history of melanoma and/or more personal history of more than on squamous cell cancer (SCC) and/or Basal Cell Cancer (BCC)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 H. Lee Moffitt Cancer Center and Research Institute Tampa Florida United States 33612
    2 Ponce School of Medicine Ponce Puerto Rico 00716

    Sponsors and Collaborators

    • H. Lee Moffitt Cancer Center and Research Institute
    • The Ponce Health Sciences University
    • University of South Florida
    • American Cancer Society, Inc.

    Investigators

    • Principal Investigator: Peter Kanetsky, Ph.D, H. Lee Moffitt Cancer Center and Research Institute

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    H. Lee Moffitt Cancer Center and Research Institute
    ClinicalTrials.gov Identifier:
    NCT03509467
    Other Study ID Numbers:
    • MCC-17984
    • MCC-19461
    First Posted:
    Apr 26, 2018
    Last Update Posted:
    Nov 16, 2021
    Last Verified:
    Nov 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by H. Lee Moffitt Cancer Center and Research Institute
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 16, 2021